LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Cutting Telix Pharmaceuticals Limited (TLX) Q2 27 Estimate To 0.05 From 0.07 2/20/2026 6:46:46 AM
  • Wedbush Is Lowering Telix Pharmaceuticals Limited (TLX) Q1 27 Estimate To 0.04 From 0.07 2/20/2026 6:46:38 AM
  • Wedbush Is Lowering Telix Pharmaceuticals Limited (TLX) FY 26 Estimate To 0.00 From 0.15 2/20/2026 6:46:27 AM
  • Wedbush Is Lowering Telix Pharmaceuticals Limited (TLX) Q4 26 Estimate To 0.02 From 0.05 2/20/2026 6:46:16 AM
  • Wedbush Is Cutting Telix Pharmaceuticals Limited (TLX) Q3 26 Estimate To 0.01 From 0.04 2/20/2026 6:46:08 AM
  • Wedbush Is Cutting Telix Pharmaceuticals Limited (TLX) Q2 26 Estimate To -0.01 From 0.03 2/20/2026 6:45:57 AM
  • Wedbush Is Lowering Telix Pharmaceuticals Limited (TLX) Q1 26 Estimate To -0.02 From 0.03 2/20/2026 6:45:49 AM
  • Wedbush Reiterates Telix Pharmaceuticals Limited (TLX) At Outperform With $22 Price Target 2/20/2026 6:45:17 AM
  • Telix Pharma Forecasts FY26 Revenue Of US$950M-US$970M 2/19/2026 9:05:11 PM
  • Telix Pharma FY'25 Revenue Jumps 56% To US$803.8 Mln 2/19/2026 9:01:34 PM
  • Telix Pharmaceuticals FY Operating Profit Drops To US$29.8 Mln From US$55.2 Mln Prior Year 2/19/2026 7:37:23 PM
  • Telix Files European Marketing Authorization Application For TLX101-Px In Brain Cancer Imaging 2/17/2026 7:51:46 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap